Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates.
Several novel gadolinium chelates conjugated with paclitaxel, colchicine and thyroxine have been prepared as MRI contrast agents targeted to tubulin and thyroxine-binding globulin, respectively.